Lymphocyte toxicity assay: A tool to assess trimethoprim-sulfamethoxazole hypersensitivity syndrome reactions in human immunodeficiency virus-infected individuals.

被引：0
|
作者：
Neuman, M [1 ]
Malkiewicz, I [1 ]
Phillips, E [1 ]
Rachlis, A [1 ]
Yeung, E [1 ]
Ong, D [1 ]
Shear, NH [1 ]
机构：
[1] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1128
引用
收藏
页码：454A / 454A
页数：1
相关论文
共 50 条
  • [11] Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection
    Rieder, MJ
    King, SM
    Read, S
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (11) : 1028 - 1031
  • [12] Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons
    Rich, JD
    Sullivan, T
    Greineder, D
    Kazanjian, PH
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 79 (05) : 409 - 414
  • [13] A SEVERE, UNUSUAL REACTION TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    KELLY, JW
    DOOLEY, DP
    LATTUADA, CP
    SMITH, CE
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (05) : 1034 - 1039
  • [14] Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus
    Canas, E
    Pachon, J
    GarciaPesquera, F
    Castillo, JR
    Viciana, P
    Cisneros, JM
    JimenezMejias, ME
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 230 - 233
  • [15] A SEVERE SYSTEMIC REACTION TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN A PATIENT INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    MARTIN, GJ
    PAPARELLO, SF
    DECKER, CF
    CLINICAL INFECTIOUS DISEASES, 1993, 16 (01) : 175 - 176
  • [16] A SEVERE HYPERSENSITIVE REACTION TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN A PATIENT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    MARINAC, JS
    STANFORD, JF
    CLINICAL INFECTIOUS DISEASES, 1993, 16 (01) : 178 - 179
  • [17] Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients
    Ribera, E
    Fernandez-Sola, A
    Juste, C
    Rovira, A
    Romero, FJ
    Armadans-Gil, L
    Ruiz, I
    Ocaña, I
    Pahissa, A
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) : 1461 - 1466
  • [18] Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection
    BelchiHernandez, J
    EspinosaParra, FJ
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1996, 76 (04) : 355 - 358
  • [19] CROSSOVER OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS FROM AEROSOLIZED PENTAMIDINE TO TRIMETHOPRIM-SULFAMETHOXAZOLE - LACK OF HEMATOLOGIC TOXICITY AND RELATIONSHIP OF SIDE-EFFECTS TO CD4+ LYMPHOCYTE COUNT
    KENNEDY, CA
    PIMENTEL, JA
    LEWIS, DE
    ANDERSON, MD
    WEISS, PJ
    OLDFIELD, EC
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) : 314 - 317
  • [20] Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients
    Ribera, E
    Pou, L
    Fernandez-Sola, A
    Campos, F
    Lopez, RM
    Ocaña, I
    Ruiz, I
    Pahissa, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3238 - 3241
12345